Replies to post #78460 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Excellent post... I especially agree with the following:

Speaking only for myself, I care ZERO when CTIX up-listing comes. I'm happy to wait for when the CEO finds the time opportune. As it's not a trade event for me, I see it as just one more step in building Cellceutix and shareholder value.

In Reply to 'TOB'
Short term CTIX traders will always be buying and selling in anticipation or reaction to [news, charts, rumours, hunches, move to other trades, (insert reason here)]

KarinCA you probably
just cost us about .20 or more on the share price.
LOTS of people here were waiting for the uplisting.
Sounds like another selloff on Monday unless we get some
good PR. -didmyhomework

Traders are a fickle group. We've seen many little rallies on Fridays in anticipation of PR, then little pullbacks if there wasn't one.

Personally, I could care less about .20 cent moves. Even the last 60 cent move meant nothing to me as CTIX is a long position for me. It costs me ZERO as this is a paper number. Only the price I buy CTIX at and sell CTIX at costs, or makes me any money.

I honestly don't know what price I'd sell at. What if CTIX hits $20, or $30, or $50, or $100 dollars? Would I sell prior to buyout or completion of all clinical trials?

I don't bother myself much with that sort of consideration yet, as I see CTIX as far from a true binary event.

Further phase trials for Brilacidin are a guarantee, one is already scheduled for Brilacidin-OM and a P3 for Brilacidin-ABSSSI appears certain from the top-line results. Other Brilacidin trials are in the works.

At least 1 additional trial for Kevetrin is poised to start, and with a successful Phase 1 trial a near certainty, I expect more than one trial coming up.

Prurisol has a trial coming up, that is the closest thing to a binary event I see in the near term. Pass or fail. But one of three drugs in clinical trials, and perhaps the one with almost no representation in the share price.

As these trials unfold. I expect more 20 cent swings than could be counted. Later I hope we'll see $5 swings at a much higher share price. Medium term it is hard to imagine the CTIX price not increasing with so many clinical trials, though anything is possible and there is always risk.

But yes, I understand that traders looking for a quick trade will sell and buy based on [whatever, insert reason]. I understand traders will fret over 20 cent moves and worry at imagined PRs, gaps, and similar. I see daily angst should CTIX drop a nickle or a couple dimes. I understand that traders who miss sell targets feel pain, and also joy when their targets are hit. All part of the game. CTIX holders are a diverse group, including insiders, longs of various commitment levels, traders of various strategies, and even a few shorts.

Speaking only for myself, I care ZERO when CTIX up-listing comes. I'm happy to wait for when the CEO finds the time opportune. As it's not a trade event for me, I see it as just one more step in building Cellceutix and shareholder value.